| Financial Year |
March 31 2023 |
| Monetary Funds |
1,480,337,145.18 |
| Held-for-trading Financial Assets |
231,757,016.13 |
| Notes Receivable |
-- |
| Accounts Receivable |
4,839.59 |
| Advances to Suppliers |
11,003,408.73 |
| Other Receivables |
1,026,101.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,791,260.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,270,656.28 |
| Total Current Assets |
1,729,190,427.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
590,565.00 |
| Investment Properties |
-- |
| Fixed Assetes |
169,221,064.56 |
| Under-construction Projects |
1,329,481.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,103,219.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,296,148.57 |
| Deferred Income Tax Assets |
2,270,798.61 |
| Other Non-Current Assets |
1,215,213.20 |
| Sub-Total of Non-Current Assets |
252,648,086.86 |
| Total Assets |
1,981,838,514.62 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
21,949,898.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,115,579.92 |
| Taxes Payable |
15,633,888.86 |
| Interest Payable |
-- |
| Dividend Payable |
225,614.47 |
| Other payables |
3,198,952.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,953,807.81 |
| Other Current Liabilities |
28,793,370.89 |
| Sub-Total of Current Liabilities |
875,334,811.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,896,272.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,026,104.54 |
| Total Liabilities |
894,360,915.86 |
| Paid-In Capital(Or Share Stock) |
118,078,600.00 |
| Capital Surplus |
471,041,673.62 |
| Surplus Reserve |
50,079,829.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
426,830,297.53 |
| Minority Stockholder's Interest |
2,553,396.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,084,924,202.00 |
| Owner's Equity（Stockholder's Equity） |
1,087,477,598.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,981,838,514.62 |
